Gril, B., Wei, D., Zimmer, A. S., Robinson, C., Khan, I., Difilippantonio, S., . . . Steeg, P. S. (2020). HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood–tumor barrier penetration unlinked to a passive marker. Neuro Oncol.

Gril, Brunilde, Debbie Wei, Alexandra S. Zimmer, Christina Robinson, Imran Khan, Simone Difilippantonio, Michael G. Overstreet, and Patricia S. Steeg. "HER2 Antibody-drug Conjugate Controls Growth of Breast Cancer Brain Metastases in Hematogenous Xenograft Models, With Heterogeneous Blood–tumor Barrier Penetration Unlinked to a Passive Marker." Neuro Oncol 2020.

Gril, Brunilde, et al. "HER2 Antibody-drug Conjugate Controls Growth of Breast Cancer Brain Metastases in Hematogenous Xenograft Models, With Heterogeneous Blood–tumor Barrier Penetration Unlinked to a Passive Marker." Neuro Oncol 2020.